Korean aesthetic device company reported on Wednesday the receipt of the US Food and Drug Administration's 510 (K) clearance to market WONTECH SANDRO DUAL laser device across the global markets, including the US and Europe.
Recently, the SANDRO DUAL was launched in Korea Nd:YAG & Alexandrite based lasers mounted on one device.
According to the company, the SANDRO DUAL can be implemented in the hybrid mode in a short time difference between two wavelengths of 755nm and 1064nm. The energy is accurately delivered to a specific area to deliver an effective and quick treatment in hair removal as well as whitening without damaging surrounding tissue.
In addition, the the SANDRO DUAL's SCS (Skin Cooling Spray) cooling system minimizes patient discomfort from pain, swelling and redness.
FDA approval streamlines access to Bristol Myers Squibb CAR T cell therapies
Emmaus Life Sciences' Endari label enhancements receive US FDA approval
Accord Healthcare introduces Dehydrated Alcohol Injection for cardiovascular indications
CARsgen Therapeutics' satri-cel NDA accepted by Chinese regulator
Sanofi receives FDA orphan drug designation for riliprubart in transplant rejection
Hoth Therapeutics reports positive interim results for HT-001 topical therapy
Breckenridge Pharmaceutical's generic for Ablysinol granted final FDA approval
Hemab Therapeutics presents bleeding disorder clinical and preclinical data at ISTH 2025 Congress